| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 42 | 2025 | 1022 | 2.420 |
Why?
|
| Computational Biology | 12 | 2020 | 862 | 1.850 |
Why?
|
| Genetic Diseases, Inborn | 15 | 2024 | 467 | 1.750 |
Why?
|
| Comparative Genomic Hybridization | 27 | 2017 | 567 | 1.670 |
Why?
|
| Software | 6 | 2020 | 731 | 1.590 |
Why?
|
| Chromosome Aberrations | 23 | 2019 | 573 | 1.450 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 43 | 2025 | 995 | 1.380 |
Why?
|
| Models, Genetic | 12 | 2025 | 748 | 1.270 |
Why?
|
| Disease | 4 | 2020 | 122 | 1.220 |
Why?
|
| Phenotype | 30 | 2025 | 4471 | 1.160 |
Why?
|
| Chromosome Disorders | 17 | 2019 | 316 | 1.150 |
Why?
|
| Genome, Human | 24 | 2025 | 1314 | 1.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2020 | 888 | 1.110 |
Why?
|
| Models, Statistical | 3 | 2020 | 482 | 1.090 |
Why?
|
| Mosaicism | 10 | 2020 | 247 | 1.070 |
Why?
|
| Genetic Variation | 11 | 2025 | 1541 | 1.070 |
Why?
|
| Gene Expression Regulation | 25 | 2023 | 2334 | 1.060 |
Why?
|
| Blood Platelets | 9 | 2019 | 315 | 1.020 |
Why?
|
| Models, Theoretical | 3 | 2020 | 360 | 1.010 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2025 | 3404 | 1.000 |
Why?
|
| Genetic Heterogeneity | 2 | 2025 | 133 | 0.910 |
Why?
|
| Sequence Analysis, DNA | 12 | 2020 | 1693 | 0.900 |
Why?
|
| Genome-Wide Association Study | 13 | 2025 | 1824 | 0.900 |
Why?
|
| Genetic Testing | 8 | 2025 | 1102 | 0.820 |
Why?
|
| Breast Neoplasms | 11 | 2025 | 2599 | 0.810 |
Why?
|
| Gene Dosage | 15 | 2013 | 436 | 0.780 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2019 | 2825 | 0.770 |
Why?
|
| Codon, Nonsense | 3 | 2021 | 138 | 0.730 |
Why?
|
| Nonsense Mediated mRNA Decay | 2 | 2021 | 39 | 0.720 |
Why?
|
| Microbiota | 5 | 2020 | 438 | 0.710 |
Why?
|
| Parkinson Disease | 2 | 2026 | 722 | 0.690 |
Why?
|
| Humans | 173 | 2026 | 130376 | 0.660 |
Why?
|
| Exome | 14 | 2025 | 1063 | 0.650 |
Why?
|
| Genomic Instability | 9 | 2018 | 245 | 0.640 |
Why?
|
| Exons | 10 | 2025 | 760 | 0.630 |
Why?
|
| Respiratory Syncytial Virus, Human | 4 | 2017 | 241 | 0.620 |
Why?
|
| Genetic Techniques | 2 | 2018 | 95 | 0.610 |
Why?
|
| Microarray Analysis | 6 | 2019 | 223 | 0.590 |
Why?
|
| Mutation | 23 | 2024 | 6095 | 0.590 |
Why?
|
| Algorithms | 6 | 2024 | 1663 | 0.580 |
Why?
|
| Gene Expression Profiling | 22 | 2016 | 1807 | 0.570 |
Why?
|
| Gametogenesis | 3 | 2017 | 26 | 0.570 |
Why?
|
| Chromosome Deletion | 14 | 2023 | 653 | 0.550 |
Why?
|
| Bayes Theorem | 3 | 2020 | 307 | 0.540 |
Why?
|
| Genes, Reporter | 2 | 2018 | 341 | 0.540 |
Why?
|
| MicroRNAs | 10 | 2015 | 889 | 0.530 |
Why?
|
| Genomics | 12 | 2022 | 1612 | 0.510 |
Why?
|
| Nerve Tissue Proteins | 12 | 2016 | 1081 | 0.510 |
Why?
|
| Sequence Deletion | 12 | 2018 | 517 | 0.500 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2017 | 395 | 0.500 |
Why?
|
| Quantitative Trait Loci | 3 | 2019 | 307 | 0.490 |
Why?
|
| Alleles | 10 | 2019 | 1675 | 0.490 |
Why?
|
| In Situ Hybridization, Fluorescence | 26 | 2016 | 742 | 0.480 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 91 | 0.470 |
Why?
|
| Gene Duplication | 10 | 2018 | 358 | 0.470 |
Why?
|
| Inheritance Patterns | 3 | 2017 | 127 | 0.470 |
Why?
|
| Germ-Line Mutation | 2 | 2014 | 372 | 0.450 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1587 | 0.450 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 157 | 0.440 |
Why?
|
| RNA, Messenger | 14 | 2016 | 2551 | 0.440 |
Why?
|
| Female | 94 | 2025 | 70325 | 0.440 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 87 | 0.440 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 285 | 0.430 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2013 | 152 | 0.430 |
Why?
|
| Nucleic Acid Hybridization | 9 | 2010 | 296 | 0.410 |
Why?
|
| Transcription, Genetic | 16 | 2017 | 1367 | 0.410 |
Why?
|
| Animals | 73 | 2026 | 33846 | 0.400 |
Why?
|
| Abnormalities, Multiple | 10 | 2023 | 964 | 0.400 |
Why?
|
| Nuclear Proteins | 13 | 2024 | 1220 | 0.390 |
Why?
|
| Epilepsy | 4 | 2013 | 863 | 0.390 |
Why?
|
| Trophoblasts | 3 | 2019 | 114 | 0.390 |
Why?
|
| Receptors, Thrombin | 4 | 2018 | 12 | 0.390 |
Why?
|
| Metagenomics | 1 | 2014 | 114 | 0.380 |
Why?
|
| Gene Deletion | 6 | 2018 | 767 | 0.380 |
Why?
|
| Bronchiolitis | 3 | 2019 | 126 | 0.380 |
Why?
|
| Drosophila Proteins | 3 | 2026 | 776 | 0.380 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 6 | 2015 | 284 | 0.360 |
Why?
|
| Viral Proteins | 1 | 2014 | 338 | 0.360 |
Why?
|
| Mice | 49 | 2025 | 18219 | 0.360 |
Why?
|
| Male | 82 | 2025 | 64453 | 0.350 |
Why?
|
| Homologous Recombination | 7 | 2022 | 97 | 0.350 |
Why?
|
| Base Sequence | 16 | 2022 | 2734 | 0.340 |
Why?
|
| Rare Diseases | 2 | 2024 | 205 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2019 | 363 | 0.340 |
Why?
|
| Genotype | 14 | 2018 | 2589 | 0.340 |
Why?
|
| Likelihood Functions | 2 | 2025 | 115 | 0.330 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2013 | 541 | 0.320 |
Why?
|
| Single-Cell Analysis | 5 | 2019 | 352 | 0.320 |
Why?
|
| Gene Regulatory Networks | 5 | 2016 | 380 | 0.310 |
Why?
|
| Platelet Activation | 3 | 2015 | 64 | 0.300 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 3 | 2025 | 401 | 0.290 |
Why?
|
| Autistic Disorder | 6 | 2013 | 395 | 0.290 |
Why?
|
| Repressor Proteins | 6 | 2021 | 763 | 0.280 |
Why?
|
| DNA Replication | 5 | 2019 | 357 | 0.280 |
Why?
|
| Cell Line, Tumor | 15 | 2019 | 3712 | 0.280 |
Why?
|
| Dictyostelium | 6 | 2004 | 115 | 0.270 |
Why?
|
| Alu Elements | 3 | 2018 | 66 | 0.270 |
Why?
|
| Genetic Markers | 4 | 2019 | 590 | 0.270 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 817 | 0.270 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 3469 | 0.270 |
Why?
|
| Signal Transduction | 11 | 2019 | 4671 | 0.270 |
Why?
|
| Polymerase Chain Reaction | 9 | 2015 | 1456 | 0.260 |
Why?
|
| Circadian Rhythm | 5 | 2007 | 316 | 0.260 |
Why?
|
| Drosophila melanogaster | 3 | 2026 | 837 | 0.260 |
Why?
|
| Heart | 3 | 2025 | 659 | 0.260 |
Why?
|
| Diaphragm | 2 | 2025 | 100 | 0.250 |
Why?
|
| Neoplasms | 2 | 2021 | 2966 | 0.250 |
Why?
|
| Nasopharynx | 2 | 2018 | 88 | 0.250 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2012 | 82 | 0.250 |
Why?
|
| Gene Expression | 7 | 2016 | 1486 | 0.250 |
Why?
|
| Genotyping Techniques | 3 | 2016 | 110 | 0.250 |
Why?
|
| Nasal Cavity | 2 | 2018 | 56 | 0.250 |
Why?
|
| Intellectual Disability | 8 | 2017 | 1085 | 0.240 |
Why?
|
| Platelet Aggregation | 3 | 2015 | 101 | 0.240 |
Why?
|
| Ataxia | 3 | 2014 | 157 | 0.240 |
Why?
|
| Proton-Translocating ATPases | 1 | 2026 | 25 | 0.230 |
Why?
|
| Glucosylceramidase | 1 | 2026 | 33 | 0.230 |
Why?
|
| Wnt4 Protein | 1 | 2025 | 23 | 0.230 |
Why?
|
| Phospholipid Transfer Proteins | 2 | 2017 | 15 | 0.230 |
Why?
|
| Palate | 1 | 2025 | 19 | 0.230 |
Why?
|
| DNA Methylation | 5 | 2019 | 1073 | 0.230 |
Why?
|
| Membrane Proteins | 7 | 2017 | 1591 | 0.230 |
Why?
|
| Gene Rearrangement | 5 | 2019 | 323 | 0.230 |
Why?
|
| Homozygote | 3 | 2019 | 535 | 0.230 |
Why?
|
| Genes, Viral | 2 | 2017 | 155 | 0.230 |
Why?
|
| Transcriptome | 5 | 2016 | 1113 | 0.230 |
Why?
|
| INDEL Mutation | 3 | 2020 | 93 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 254 | 0.230 |
Why?
|
| Pregnancy | 12 | 2020 | 7387 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2018 | 18 | 0.220 |
Why?
|
| DNA Repair | 4 | 2019 | 571 | 0.220 |
Why?
|
| Urinary Tract | 1 | 2025 | 54 | 0.220 |
Why?
|
| Cell Differentiation | 11 | 2019 | 1921 | 0.220 |
Why?
|
| Child, Preschool | 25 | 2025 | 14955 | 0.220 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2025 | 78 | 0.220 |
Why?
|
| Nerve Degeneration | 1 | 2026 | 132 | 0.220 |
Why?
|
| Trisomy | 4 | 2011 | 111 | 0.220 |
Why?
|
| Hypothalamus | 3 | 2013 | 198 | 0.220 |
Why?
|
| Germ Cells | 3 | 2014 | 199 | 0.220 |
Why?
|
| Translocation, Genetic | 4 | 2012 | 344 | 0.210 |
Why?
|
| Bronchiolitis, Viral | 2 | 2016 | 29 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2017 | 87 | 0.210 |
Why?
|
| Infant | 21 | 2025 | 13253 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2019 | 94 | 0.210 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 359 | 0.210 |
Why?
|
| Interferons | 2 | 2017 | 135 | 0.210 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 172 | 0.210 |
Why?
|
| DNA Helicases | 4 | 2024 | 236 | 0.210 |
Why?
|
| Anophthalmos | 1 | 2024 | 23 | 0.200 |
Why?
|
| Gene Amplification | 2 | 2014 | 220 | 0.200 |
Why?
|
| Coloboma | 1 | 2024 | 40 | 0.200 |
Why?
|
| DNA | 7 | 2016 | 1400 | 0.200 |
Why?
|
| Microphthalmos | 1 | 2024 | 54 | 0.200 |
Why?
|
| Genes, myc | 2 | 2015 | 96 | 0.200 |
Why?
|
| Tetralogy of Fallot | 1 | 2025 | 169 | 0.200 |
Why?
|
| Urogenital Abnormalities | 1 | 2025 | 154 | 0.200 |
Why?
|
| Prevotella | 2 | 2020 | 9 | 0.200 |
Why?
|
| Genome, Viral | 1 | 2024 | 167 | 0.200 |
Why?
|
| Transcription Factors | 8 | 2025 | 2423 | 0.200 |
Why?
|
| Virus Replication | 2 | 2024 | 607 | 0.190 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 1484 | 0.190 |
Why?
|
| Disease Models, Animal | 15 | 2025 | 4666 | 0.190 |
Why?
|
| Neoplasm Metastasis | 5 | 2017 | 710 | 0.190 |
Why?
|
| Developmental Disabilities | 6 | 2016 | 780 | 0.190 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2022 | 16 | 0.190 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2018 | 281 | 0.190 |
Why?
|
| Anorectal Malformations | 1 | 2022 | 17 | 0.190 |
Why?
|
| Scimitar Syndrome | 1 | 2023 | 51 | 0.190 |
Why?
|
| DNA-Binding Proteins | 5 | 2015 | 1948 | 0.190 |
Why?
|
| Moraxella | 2 | 2019 | 14 | 0.190 |
Why?
|
| Adult | 25 | 2025 | 31095 | 0.180 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2022 | 48 | 0.180 |
Why?
|
| Streptococcus | 2 | 2019 | 64 | 0.180 |
Why?
|
| Esophageal Atresia | 1 | 2022 | 52 | 0.180 |
Why?
|
| RNA, Viral | 1 | 2024 | 499 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 2 | 2012 | 36 | 0.180 |
Why?
|
| Cell Line | 9 | 2019 | 2557 | 0.180 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2019 | 107 | 0.180 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 73 | 0.180 |
Why?
|
| Child | 26 | 2025 | 26106 | 0.170 |
Why?
|
| Prenatal Diagnosis | 5 | 2019 | 609 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 17 | 2016 | 4714 | 0.170 |
Why?
|
| MEF2 Transcription Factors | 2 | 2019 | 34 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2011 | 145 | 0.170 |
Why?
|
| Karyotyping | 9 | 2014 | 308 | 0.170 |
Why?
|
| Telomere | 4 | 2008 | 218 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2017 | 2464 | 0.170 |
Why?
|
| Rett Syndrome | 3 | 2015 | 229 | 0.170 |
Why?
|
| Chromosome Breakpoints | 6 | 2019 | 82 | 0.170 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 154 | 0.170 |
Why?
|
| Mutation Rate | 3 | 2024 | 68 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2011 | 77 | 0.170 |
Why?
|
| Staphylococcus | 2 | 2018 | 68 | 0.160 |
Why?
|
| Thrombosis | 3 | 2015 | 499 | 0.160 |
Why?
|
| Adolescent | 21 | 2025 | 20716 | 0.160 |
Why?
|
| Chromosome Mapping | 9 | 2023 | 1046 | 0.160 |
Why?
|
| Young Adult | 13 | 2019 | 9979 | 0.160 |
Why?
|
| Myocytes, Cardiac | 4 | 2023 | 670 | 0.160 |
Why?
|
| Hematopoiesis | 3 | 2014 | 212 | 0.160 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2015 | 81 | 0.160 |
Why?
|
| Hospitals | 1 | 2023 | 437 | 0.160 |
Why?
|
| Cytogenetic Analysis | 5 | 2012 | 78 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2023 | 521 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2018 | 1000 | 0.150 |
Why?
|
| Pyridines | 2 | 2018 | 258 | 0.150 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 18 | 0.150 |
Why?
|
| CD36 Antigens | 1 | 2019 | 35 | 0.150 |
Why?
|
| Coronary Vessels | 1 | 2023 | 524 | 0.150 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2015 | 83 | 0.150 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 78 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 378 | 0.150 |
Why?
|
| Thrombopoiesis | 1 | 2019 | 9 | 0.150 |
Why?
|
| Cohort Studies | 11 | 2018 | 5038 | 0.150 |
Why?
|
| Rhinovirus | 2 | 2016 | 67 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 28 | 0.150 |
Why?
|
| Nasal Mucosa | 1 | 2019 | 88 | 0.140 |
Why?
|
| Osteochondrodysplasias | 2 | 2012 | 68 | 0.140 |
Why?
|
| Megakaryocytes | 1 | 2019 | 40 | 0.140 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 27 | 0.140 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 225 | 0.140 |
Why?
|
| Myocardium | 3 | 2007 | 857 | 0.140 |
Why?
|
| Lactones | 1 | 2018 | 39 | 0.140 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 122 | 0.140 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 448 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2011 | 143 | 0.140 |
Why?
|
| WAGR Syndrome | 1 | 2017 | 7 | 0.140 |
Why?
|
| Evolution, Molecular | 4 | 2024 | 645 | 0.130 |
Why?
|
| Biological Assay | 1 | 2018 | 106 | 0.130 |
Why?
|
| Influenza, Human | 2 | 2015 | 702 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 877 | 0.130 |
Why?
|
| Genetic Association Studies | 4 | 2015 | 822 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 116 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 1206 | 0.130 |
Why?
|
| Cell Cycle Proteins | 3 | 2018 | 710 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 589 | 0.130 |
Why?
|
| Aneuploidy | 3 | 2014 | 136 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2018 | 500 | 0.130 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 32 | 0.130 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.130 |
Why?
|
| Influenza Vaccines | 2 | 2013 | 501 | 0.130 |
Why?
|
| Phosphofructokinase-1 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Chromosome Breakage | 6 | 2011 | 154 | 0.130 |
Why?
|
| Paracrine Communication | 1 | 2017 | 67 | 0.130 |
Why?
|
| Bone Marrow | 1 | 2019 | 317 | 0.130 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 1870 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 384 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 1391 | 0.130 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.130 |
Why?
|
| Hormones | 1 | 2017 | 162 | 0.130 |
Why?
|
| CELF1 Protein | 1 | 2016 | 34 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 211 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2014 | 121 | 0.120 |
Why?
|
| Ataxins | 6 | 2013 | 109 | 0.120 |
Why?
|
| Loss of Heterozygosity | 2 | 2015 | 123 | 0.120 |
Why?
|
| Influenza B virus | 2 | 2015 | 102 | 0.120 |
Why?
|
| Pedigree | 6 | 2019 | 1673 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 247 | 0.120 |
Why?
|
| Recombination, Genetic | 3 | 2019 | 422 | 0.120 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 61 | 0.120 |
Why?
|
| Antigens, Viral | 2 | 2017 | 391 | 0.120 |
Why?
|
| Transgenes | 2 | 2014 | 322 | 0.120 |
Why?
|
| Myocardial Contraction | 2 | 2007 | 243 | 0.120 |
Why?
|
| Pharynx | 1 | 2016 | 65 | 0.120 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2016 | 69 | 0.120 |
Why?
|
| Carrier Proteins | 3 | 2018 | 1000 | 0.120 |
Why?
|
| Ataxin-1 | 6 | 2013 | 166 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 420 | 0.120 |
Why?
|
| Epithelial Cells | 3 | 2016 | 907 | 0.120 |
Why?
|
| Picornaviridae Infections | 1 | 2016 | 49 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 238 | 0.120 |
Why?
|
| Prognosis | 3 | 2021 | 4862 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2015 | 15 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 76 | 0.110 |
Why?
|
| Drosophila | 3 | 2015 | 772 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 2015 | 59 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 498 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 715 | 0.110 |
Why?
|
| Spliceosomes | 1 | 2015 | 47 | 0.110 |
Why?
|
| Endonucleases | 1 | 2015 | 52 | 0.110 |
Why?
|
| Mutagenesis, Insertional | 3 | 2015 | 151 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 3 | 2012 | 97 | 0.110 |
Why?
|
| Data Mining | 1 | 2015 | 66 | 0.110 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2015 | 38 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2016 | 1444 | 0.110 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 42 | 0.110 |
Why?
|
| Infant, Newborn | 12 | 2017 | 8528 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2009 | 231 | 0.110 |
Why?
|
| Chromosome Duplication | 4 | 2019 | 146 | 0.110 |
Why?
|
| Chorionic Villi Sampling | 2 | 2012 | 44 | 0.110 |
Why?
|
| Primates | 1 | 2015 | 81 | 0.110 |
Why?
|
| Retrospective Studies | 8 | 2023 | 17502 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2017 | 290 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2014 | 341 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2019 | 1572 | 0.110 |
Why?
|
| Endogenous Retroviruses | 1 | 2014 | 18 | 0.110 |
Why?
|
| Amniocentesis | 2 | 2012 | 77 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 186 | 0.110 |
Why?
|
| Williams Syndrome | 2 | 2012 | 42 | 0.110 |
Why?
|
| Rotavirus Infections | 1 | 2017 | 282 | 0.110 |
Why?
|
| Blood Cells | 1 | 2014 | 53 | 0.110 |
Why?
|
| Biomarkers | 3 | 2020 | 3381 | 0.110 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 11 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 165 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 137 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2015 | 117 | 0.110 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2014 | 10 | 0.110 |
Why?
|
| Contig Mapping | 1 | 2014 | 46 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 75 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2012 | 148 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2017 | 628 | 0.100 |
Why?
|
| Reproducibility of Results | 8 | 2017 | 2898 | 0.100 |
Why?
|
| Fathers | 1 | 2014 | 74 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 494 | 0.100 |
Why?
|
| Recurrence | 2 | 2014 | 1470 | 0.100 |
Why?
|
| Proteome | 2 | 2014 | 286 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2013 | 33 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 437 | 0.100 |
Why?
|
| Mice, Knockout | 6 | 2025 | 3829 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 260 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.100 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 2099 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 38 | 0.100 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 25 | 0.100 |
Why?
|
| Fetus | 1 | 2016 | 566 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1270 | 0.100 |
Why?
|
| Barrett Esophagus | 2 | 2009 | 349 | 0.100 |
Why?
|
| Fragile X Syndrome | 1 | 2014 | 148 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 600 | 0.100 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 87 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 294 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2014 | 452 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 111 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 51 | 0.100 |
Why?
|
| Down-Regulation | 5 | 2017 | 649 | 0.100 |
Why?
|
| Tremor | 1 | 2014 | 126 | 0.100 |
Why?
|
| Brain | 5 | 2025 | 3174 | 0.100 |
Why?
|
| Chromosomes, Human | 3 | 2008 | 119 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 108 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 62 | 0.090 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2013 | 128 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 89 | 0.090 |
Why?
|
| Cell Communication | 2 | 2003 | 189 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2013 | 195 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 184 | 0.090 |
Why?
|
| ras Proteins | 1 | 2013 | 142 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 297 | 0.090 |
Why?
|
| Platelet Adhesiveness | 1 | 2012 | 34 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2019 | 306 | 0.090 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 60 | 0.090 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2013 | 176 | 0.090 |
Why?
|
| Carnitine | 1 | 2012 | 70 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2012 | 48 | 0.090 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 22 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 3 | 2024 | 411 | 0.090 |
Why?
|
| Arteriosclerosis | 1 | 2012 | 110 | 0.090 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 34 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2012 | 53 | 0.090 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 26 | 0.090 |
Why?
|
| Cerebellum | 3 | 2011 | 440 | 0.090 |
Why?
|
| Phylogeny | 1 | 2014 | 687 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 192 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 67 | 0.090 |
Why?
|
| Texas | 3 | 2017 | 3642 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2014 | 323 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2008 | 966 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 178 | 0.090 |
Why?
|
| Syndrome | 5 | 2014 | 1157 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 420 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2019 | 968 | 0.090 |
Why?
|
| Mothers | 1 | 2014 | 374 | 0.080 |
Why?
|
| Cartilage | 2 | 2008 | 52 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2012 | 164 | 0.080 |
Why?
|
| Neurons | 2 | 2025 | 2025 | 0.080 |
Why?
|
| Homeodomain Proteins | 3 | 2025 | 562 | 0.080 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 756 | 0.080 |
Why?
|
| Chromosome Banding | 4 | 2014 | 135 | 0.080 |
Why?
|
| Sexual Development | 1 | 2010 | 23 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 53 | 0.080 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 2333 | 0.080 |
Why?
|
| Frameshift Mutation | 2 | 2022 | 202 | 0.080 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 125 | 0.080 |
Why?
|
| Family Health | 1 | 2011 | 241 | 0.080 |
Why?
|
| Gene Frequency | 3 | 2018 | 731 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1878 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 269 | 0.080 |
Why?
|
| Cell Survival | 3 | 2018 | 831 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 98 | 0.080 |
Why?
|
| Social Behavior | 1 | 2012 | 213 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2010 | 140 | 0.080 |
Why?
|
| Autism Spectrum Disorder | 1 | 2015 | 450 | 0.080 |
Why?
|
| Medical Records | 1 | 2010 | 175 | 0.080 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2012 | 212 | 0.080 |
Why?
|
| Purkinje Cells | 2 | 2014 | 165 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2011 | 174 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 698 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2010 | 86 | 0.080 |
Why?
|
| Sensitivity and Specificity | 7 | 2009 | 2088 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2010 | 137 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1799 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 192 | 0.080 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 61 | 0.080 |
Why?
|
| Inhibin-beta Subunits | 1 | 2009 | 18 | 0.070 |
Why?
|
| Sex Chromosomes | 1 | 2009 | 29 | 0.070 |
Why?
|
| Microdissection | 1 | 2009 | 13 | 0.070 |
Why?
|
| Cells, Cultured | 6 | 2013 | 2895 | 0.070 |
Why?
|
| Middle Aged | 9 | 2018 | 28370 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2012 | 490 | 0.070 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2012 | 237 | 0.070 |
Why?
|
| De Lange Syndrome | 2 | 2019 | 44 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2011 | 323 | 0.070 |
Why?
|
| Syndactyly | 1 | 2008 | 24 | 0.070 |
Why?
|
| RNA Editing | 1 | 2008 | 31 | 0.070 |
Why?
|
| Mice, Mutant Strains | 4 | 2011 | 355 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 82 | 0.070 |
Why?
|
| Lasers | 1 | 2009 | 111 | 0.070 |
Why?
|
| Extremities | 1 | 2008 | 73 | 0.070 |
Why?
|
| K562 Cells | 2 | 2019 | 97 | 0.070 |
Why?
|
| Protozoan Proteins | 3 | 2004 | 127 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2008 | 7 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 486 | 0.070 |
Why?
|
| Somatomedins | 1 | 2008 | 33 | 0.070 |
Why?
|
| Trastuzumab | 2 | 2019 | 136 | 0.070 |
Why?
|
| Hypothalamic Diseases | 1 | 2008 | 40 | 0.070 |
Why?
|
| Vaccination | 1 | 2013 | 1051 | 0.070 |
Why?
|
| Oleic Acid | 1 | 2007 | 16 | 0.070 |
Why?
|
| Biological Clocks | 1 | 2007 | 28 | 0.070 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2007 | 38 | 0.070 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 20 | 0.070 |
Why?
|
| Penetrance | 3 | 2012 | 108 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 152 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 156 | 0.060 |
Why?
|
| Schwann Cells | 1 | 2007 | 54 | 0.060 |
Why?
|
| Platelet Count | 2 | 2019 | 139 | 0.060 |
Why?
|
| Curcumin | 1 | 2007 | 40 | 0.060 |
Why?
|
| DiGeorge Syndrome | 1 | 2008 | 83 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2007 | 79 | 0.060 |
Why?
|
| Antimanic Agents | 1 | 2007 | 33 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 665 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 312 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 175 | 0.060 |
Why?
|
| Angelman Syndrome | 1 | 2007 | 67 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2397 | 0.060 |
Why?
|
| Genes, tat | 1 | 2006 | 10 | 0.060 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 135 | 0.060 |
Why?
|
| Cell Separation | 3 | 2018 | 220 | 0.060 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2006 | 22 | 0.060 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2006 | 28 | 0.060 |
Why?
|
| Heterochromatin | 1 | 2006 | 53 | 0.060 |
Why?
|
| Retroviridae | 1 | 2006 | 182 | 0.060 |
Why?
|
| Body Composition | 1 | 2009 | 543 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2018 | 599 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 128 | 0.060 |
Why?
|
| Genetic Counseling | 3 | 2017 | 237 | 0.060 |
Why?
|
| Cyclins | 1 | 2006 | 93 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2007 | 301 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 106 | 0.060 |
Why?
|
| Protein Biosynthesis | 3 | 2016 | 572 | 0.060 |
Why?
|
| Hair Diseases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 136 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2015 | 3357 | 0.060 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2025 | 14 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 191 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2005 | 5 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 291 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2013 | 412 | 0.060 |
Why?
|
| Periodicity | 1 | 2005 | 48 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2014 | 809 | 0.060 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 109 | 0.060 |
Why?
|
| Cranial Sutures | 1 | 2005 | 32 | 0.060 |
Why?
|
| Anxiety | 1 | 2012 | 1008 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2016 | 6433 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 322 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 302 | 0.050 |
Why?
|
| Cell Cycle | 4 | 2011 | 597 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 413 | 0.050 |
Why?
|
| Jejunum | 1 | 2005 | 123 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2025 | 133 | 0.050 |
Why?
|
| Monocytes | 1 | 2006 | 336 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 2012 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2017 | 585 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 395 | 0.050 |
Why?
|
| Hypoglycemia | 2 | 2017 | 183 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 382 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2009 | 801 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2014 | 330 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 525 | 0.050 |
Why?
|
| Lysosomes | 1 | 2026 | 269 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2006 | 373 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2025 | 274 | 0.050 |
Why?
|
| Monosomy | 1 | 2003 | 24 | 0.050 |
Why?
|
| SOXF Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
|
| Trans-Activators | 3 | 2016 | 701 | 0.050 |
Why?
|
| Endothelium | 1 | 2023 | 60 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2024 | 226 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6783 | 0.050 |
Why?
|
| Meiosis | 1 | 2003 | 110 | 0.050 |
Why?
|
| Aged | 4 | 2018 | 20863 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2006 | 897 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 306 | 0.050 |
Why?
|
| Proteins | 2 | 2011 | 1008 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 287 | 0.050 |
Why?
|
| Risk | 2 | 2015 | 721 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 345 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 327 | 0.050 |
Why?
|
| Risk Factors | 2 | 2014 | 10946 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2010 | 902 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 492 | 0.050 |
Why?
|
| Protein Interaction Maps | 2 | 2013 | 93 | 0.050 |
Why?
|
| Cleft Lip | 1 | 2025 | 193 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 195 | 0.050 |
Why?
|
| Cleft Palate | 1 | 2025 | 219 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 192 | 0.050 |
Why?
|
| Macrophages | 1 | 2006 | 661 | 0.040 |
Why?
|
| Apoptosis | 3 | 2019 | 1829 | 0.040 |
Why?
|
| Asthma | 1 | 2010 | 921 | 0.040 |
Why?
|
| Stem Cells | 1 | 2006 | 703 | 0.040 |
Why?
|
| Machine Learning | 1 | 2025 | 380 | 0.040 |
Why?
|
| Critical Care | 2 | 2017 | 685 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 553 | 0.040 |
Why?
|
| Length of Stay | 2 | 2017 | 1400 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 251 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 403 | 0.040 |
Why?
|
| Age of Onset | 2 | 2013 | 595 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 117 | 0.040 |
Why?
|
| Siblings | 2 | 2012 | 201 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 686 | 0.040 |
Why?
|
| Embryonic Development | 2 | 2017 | 201 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 302 | 0.040 |
Why?
|
| Rats | 4 | 2007 | 3371 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 691 | 0.040 |
Why?
|
| Genes, Protozoan | 3 | 2004 | 23 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2290 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2017 | 731 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1242 | 0.040 |
Why?
|
| Ataxin-7 | 2 | 2010 | 13 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 538 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2002 | 671 | 0.040 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2019 | 5 | 0.040 |
Why?
|
| Time Factors | 4 | 2013 | 6196 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2016 | 813 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Lymphangioma, Cystic | 1 | 2019 | 16 | 0.040 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2019 | 18 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2011 | 60 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 51 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 119 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 1172 | 0.040 |
Why?
|
| Achondroplasia | 1 | 2019 | 24 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2015 | 583 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 30 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 25 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2011 | 65 | 0.040 |
Why?
|
| Kidney | 1 | 2025 | 1277 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 176 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 110 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 223 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2019 | 82 | 0.040 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2019 | 53 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2008 | 234 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 52 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 373 | 0.030 |
Why?
|
| Hospitalization | 2 | 2018 | 1933 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 49 | 0.030 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 96 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 45 | 0.030 |
Why?
|
| Veratrum Alkaloids | 1 | 2017 | 12 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 147 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 296 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 2017 | 10 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 52 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 37 | 0.030 |
Why?
|
| Chondrocytes | 2 | 2008 | 48 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2013 | 828 | 0.030 |
Why?
|
| Haemophilus | 1 | 2016 | 13 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 2016 | 39 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 97 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 116 | 0.030 |
Why?
|
| RNA Stability | 2 | 2008 | 75 | 0.030 |
Why?
|
| Viral Fusion Proteins | 1 | 2017 | 74 | 0.030 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 169 | 0.030 |
Why?
|
| Chromatin | 2 | 2012 | 502 | 0.030 |
Why?
|
| Perfusion | 2 | 2007 | 209 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 161 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 104 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 115 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2017 | 82 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 142 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 154 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 276 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 177 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 480 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 200 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 9 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 316 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2015 | 31 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 404 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2008 | 416 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 42 | 0.030 |
Why?
|
| Common Cold | 1 | 2015 | 24 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 56 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 51 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2015 | 48 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2015 | 52 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 50 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 960 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2015 | 87 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 310 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 246 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 934 | 0.030 |
Why?
|
| Ischemia | 1 | 2018 | 359 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 252 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 38 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2018 | 488 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 279 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 585 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 89 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 779 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2015 | 100 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 150 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2015 | 142 | 0.030 |
Why?
|
| Rotavirus | 1 | 2017 | 367 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 316 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 417 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 237 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 410 | 0.030 |
Why?
|
| Embolism, Cholesterol | 1 | 2013 | 2 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 275 | 0.030 |
Why?
|
| Microcephaly | 1 | 2017 | 348 | 0.030 |
Why?
|
| Poland | 1 | 2013 | 56 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 219 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 555 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 454 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 65 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 87 | 0.030 |
Why?
|
| Ribosomes | 1 | 2014 | 123 | 0.030 |
Why?
|
| Age Factors | 2 | 2014 | 2829 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 731 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 199 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 2013 | 34 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1209 | 0.020 |
Why?
|
| Base Composition | 1 | 2013 | 66 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2015 | 381 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 51 | 0.020 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2013 | 52 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 450 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 108 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 870 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 718 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 165 | 0.020 |
Why?
|
| Hypothermia | 1 | 2013 | 61 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 1107 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 566 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 348 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 398 | 0.020 |
Why?
|
| Base Pairing | 1 | 2012 | 40 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2013 | 244 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 81 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 358 | 0.020 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2012 | 35 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 252 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 706 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 453 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 396 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 202 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 80 | 0.020 |
Why?
|
| Corticosterone | 1 | 2012 | 49 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 805 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 84 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 260 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 341 | 0.020 |
Why?
|
| Glucose | 2 | 2007 | 852 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 104 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2011 | 49 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 334 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 67 | 0.020 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2011 | 18 | 0.020 |
Why?
|
| Models, Biological | 2 | 2008 | 1383 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 141 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 47 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 324 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1073 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 253 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 591 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 149 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 255 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 358 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 82 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 35 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 192 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2012 | 145 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 190 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 724 | 0.020 |
Why?
|
| Calcium Channels, N-Type | 1 | 2010 | 46 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1595 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2004 | 1059 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 235 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 241 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 451 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 348 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 184 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 501 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 254 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 493 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 289 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 322 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12836 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 290 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 82 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 12 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 52 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 25 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 64 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 615 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2012 | 232 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 360 | 0.020 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2008 | 30 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 120 | 0.020 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 20 | 0.020 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2008 | 32 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 198 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2011 | 345 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 28 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 232 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3030 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 142 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 410 | 0.020 |
Why?
|
| United States | 2 | 2016 | 11868 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 95 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 22 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 98 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2008 | 87 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 177 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 43 | 0.020 |
Why?
|
| PAX6 Transcription Factor | 1 | 2007 | 36 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 277 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2009 | 173 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 72 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 275 | 0.020 |
Why?
|
| Glycogenolysis | 1 | 2007 | 10 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2007 | 29 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 39 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 57 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 85 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2007 | 9 | 0.020 |
Why?
|
| Family | 1 | 2011 | 584 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 59 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 59 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 74 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 441 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 785 | 0.020 |
Why?
|
| P-Selectin | 1 | 2007 | 69 | 0.020 |
Why?
|
| Medicare | 1 | 2010 | 440 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2007 | 61 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 91 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 86 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 98 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 122 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2007 | 191 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 147 | 0.020 |
Why?
|
| Cognition | 1 | 2012 | 817 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2006 | 23 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 20 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 56 | 0.020 |
Why?
|
| Cyclin T | 1 | 2006 | 31 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 498 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 434 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 305 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2006 | 63 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2007 | 225 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 372 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 83 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 2007 | 150 | 0.010 |
Why?
|
| RNA, Ribosomal, 5.8S | 1 | 2005 | 4 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2007 | 461 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 675 | 0.010 |
Why?
|
| Dendrites | 1 | 2007 | 184 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 54 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 2005 | 61 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 1583 | 0.010 |
Why?
|
| Uncoupling Protein 3 | 1 | 2005 | 8 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 2005 | 10 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2005 | 25 | 0.010 |
Why?
|
| Animals, Suckling | 1 | 2005 | 51 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2005 | 23 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2005 | 46 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 441 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 343 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1244 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 708 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2005 | 149 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 983 | 0.010 |
Why?
|
| Myosin Type I | 1 | 2004 | 2 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2007 | 400 | 0.010 |
Why?
|
| Cellulase | 1 | 2004 | 6 | 0.010 |
Why?
|
| Fasting | 1 | 2006 | 304 | 0.010 |
Why?
|
| Spores, Protozoan | 1 | 2004 | 18 | 0.010 |
Why?
|
| RNA, Protozoan | 1 | 2004 | 10 | 0.010 |
Why?
|
| Binding Sites | 1 | 2007 | 1136 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 70 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 227 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 573 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 1109 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1547 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 479 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 196 | 0.010 |
Why?
|
| Leukocytes | 1 | 2005 | 207 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1655 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 489 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2009 | 687 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 353 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 589 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 198 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5159 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 313 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 251 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2003 | 32 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 602 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 80 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 722 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 361 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 715 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 228 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 204 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 319 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1483 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 191 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2003 | 185 | 0.010 |
Why?
|
| Genome, Protozoan | 1 | 2002 | 25 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 975 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 766 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1210 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 1127 | 0.010 |
Why?
|
| Hippocampus | 1 | 2007 | 798 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 1223 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3747 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 515 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 702 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 692 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1316 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 1343 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 3795 | 0.010 |
Why?
|